Temporal Trends and Patient Characteristics Associated With Drug Utilisation After First-Ever Stroke: Insights From Chronic Disease Registry Data in Singapore.

INTRODUCTION

Data on drug utilisation among stroke patients of Asian ethnicities are lacking. The objectives of the study were to examine the temporal trends and patient characteristics associated with prescription of thrombolytic, antithrombotic and statin medications among patients with first-ever stroke.

MATERIALS AND METHODS

First-ever ischaemic and haemorrhagic stroke patients admitted to 2 Singapore tertiary hospitals between 2010‒2014 were included. Data were extracted from the National Healthcare Group Chronic Disease Management System. Association between drug utilisation and admission year, as well as characteristics associated with drug use, were explored using multivariable logistic regression.

RESULTS

There was an increasing trend in the combined use of all 3 guideline medications in ischaemic stroke patients ( <0.001)-specifically thrombolytic agents ( <0.001), oral antithrombotics ( = 0.002) and statins ( = 0.003) at discharge. Among antithrombotics, the use of clopidogrel ( <0.001) and aspirin-clopidogrel ( <0.001) had increased, whereas prescription of dipyridamole ( <0.001) and aspirin-dipyridamole ( <0.001) had declined. For statins, the increase in atorvastatin prescription ( <0.001) was accompanied by decreasing use of simvastatin ( <0.001). Age, ethnicity and certain comorbidities (hyperlipidaemia, atrial fibrillation and chronic kidney disease) were associated with the combined use of all 3 guideline medications ( <0.05). In haemorrhagic stroke, prescription of statins at discharge were comparatively lower.

CONCLUSION

This study reveals changes in prescription behaviour over time in a multiethnic Asian population with first-ever stroke. Patient characteristics including younger age, Malay ethnicity and certain comorbidities (i.e. hyperlipidaemia, atrial fibrillation) were associated with the combined use of all 3 guideline medications among ischaemic stroke patients.